Literature DB >> 9891765

Gastrointestinal stromal tumours.

M Miettinen1, M Sarlomo-Rikala, J Lasota.   

Abstract

Gastrointestinal stromal tumour (GIST) is the designation used here to identify the most common subset of gastrointestinal mesenchymal tumours specific to those sites. These tumours have unique histological, immunophenotypic and molecular genetic features that set them apart from typical smooth muscle tumours and schwannomas; however, by tradition, they have been classified as GI-smooth muscle tumours, or stromal tumours/smooth muscle tumours. GISTs occur predominantly in persons over 40 years of age with an equal sex incidence. Benign GISTs outnumber the malignant ones by a margin of 10:1. GISTs occur throughout the gastrointestinal tract, but are most common in the stomach (60-70%) and small intestine (30%). GISTs are rare in esophagus, colon and rectum. Histologically they may show a spindle cell or epithelioid pattern (the former largely corresponds with the designation of cellular leiomyoma and the latter with that of leiomyoblastoma). Immunohistochemically most GISTs are positive for CD34 and c-kit protein (CD117); the latter is quite specific for GISTs among mesenchymal tumours. Genetically GISTs commonly show DNA losses in the long arm of chromosome 14, and c-kit gene mutations occur at least in some cases. c-kit is also expressed in the interstitial cells of Cajal, the gastrointestinal pacemaker cells, and relationship of GISTs to these cells has been proposed recently. GISTs differ histologically, immunohistochemically and genetically from typical (esophageal) leiomyomas that are negative for c-kit and CD34 and neither show DNA-losses in 14q nor c-kit mutations. Evaluation of malignancy of GISTs is based on mitotic count, tumour size and extra-gastrointestinal spread. Tumours with mitotic counts higher than 5/10 high power fields or larger than 10 cm have a significant risk for recurrence and metastasis and are considered histologically malignant; however, some tumours with mitotic activity < 1/10HPF may metastasize indicating some uncertainty in malignant potential of GISTs, especially those larger than 5 cm.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891765

Source DB:  PubMed          Journal:  Ann Chir Gynaecol        ISSN: 0355-9521


  53 in total

1.  Recurrent gastrointestinal bleed.

Authors:  K T Lim; B Mahendran; P K Rajpal
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

2.  Multiple malignant gastric stromal tumors in a young female.

Authors:  Stefanos Dokas; George Giannakoulas; George Karkavelas; Athanasios Papadopoulos; Georgia Lazaraki; Spyridon Papavramidis
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

3.  A hidden cause of upper gastrointestinal bleeding.

Authors:  S Ali; J Addley; S Johnston; D Carey; D McManus
Journal:  BMJ Case Rep       Date:  2011-02-17

4.  Gastrointestinal stromal tumor of the stomach: How to manage?

Authors:  Kazuya Akahoshi; Masafumi Oya
Journal:  World J Gastrointest Endosc       Date:  2010-08-16

5.  Gastric malignant schwannoma presenting with upper gastrointestinal bleeding: a case report.

Authors:  Masashi Takemura; Kayo Yoshida; Mamiko Takii; Katsunobu Sakurai; Akishige Kanazawa
Journal:  J Med Case Rep       Date:  2012-01-25

6.  Spindle cell tumor of the distal rectum.

Authors:  Anil M Bahadursingh; Parsia A Vagefi; Antonio Howell; Charlene Prather; Walter E Longo
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

7.  Transverse colon schwannoma treated by endoscopic mucosal resection: A case report.

Authors:  Daryl Ramai; Jonathan Lai; Kinesh Changela; Madhavi Reddy; Ghulamullah Shahzad
Journal:  Mol Clin Oncol       Date:  2017-09-19

8.  Schwannoma of the Colon.

Authors:  Ronaldo Nonose; Alberto Youssef Lahan; Juliana Santos Valenciano; Carlos Augusto Real Martinez
Journal:  Case Rep Gastroenterol       Date:  2009-09-22

Review 9.  Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate.

Authors:  Madoka Hamada; Kazuhide Ozaki; Tadashi Horimi; Akihito Tsuji; Yoshitsugu Nasu; Jun Iwata; Yusuke Nagata
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

10.  Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors.

Authors:  Eva Wardelmann; Aksana Hrychyk; Sabine Merkelbach-Bruse; Katharina Pauls; Jennifer Goldstein; Peter Hohenberger; Inge Losen; Christoph Manegold; Reinhard Büttner; Torsten Pietsch
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.